Liqiang Hu Selected Research

Liqiang Hu Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 08/2011
4	Pancreatitis 02/2022 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2013
2	COVID-19 01/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 11/2018
1	Diabetes Complications 07/2022
1	Body Weight (Weight, Body) 07/2022
1	Insulin Resistance 07/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Infections 01/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Carcinoma (Carcinomatosis) 08/2020
1	Immune System Diseases (Immune Disorders) 08/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Arteriosclerosis Obliterans 01/2020
1	Liver Neoplasms (Liver Cancer) 10/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Diabetes Mellitus 10/2018
1	Obesity 01/2018
1	Chondrosarcoma 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Necrosis 01/2017
1	Disease Progression 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Adenocarcinoma 09/2015
1	Hypoxia (Hypoxemia) 05/2013
1	Leukemia 08/2011

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 04/2013
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	VaccinesIBA 01/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Gemcitabine FDA Link 11/2018 - 09/2015
2	OSI 027IBA 01/2017 - 09/2015
2	Therapeutic UsesIBA 01/2017 - 09/2015
1	Histidine (L-Histidine)FDA Link 07/2022
1	AcidsIBA 07/2022
1	Amino Acids FDA Link 07/2022
1	Blood Glucose (Blood Sugar)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2022
1	Uric Acid (Urate)IBA 07/2022
1	LipidsIBA 07/2022
1	chaiqin chengqiIBA 02/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	taurolithocholic acid 3-sulfate (TLC-S)IBA 05/2021
1	NucleotidesIBA 01/2021
1	Proteolysis Targeting ChimeraIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Imatinib Mesylate (Gleevec)FDA Link 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 08/2020
1	GlycopeptidesIBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	HSP27 Heat-Shock ProteinsIBA 01/2020
1	N-end cysteine peptide tumor-homing peptideIBA 01/2019
1	IntegrinsIBA 01/2019
1	UbiquitinIBA 01/2019
1	Neuropilin-1IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Ubiquitin-Specific ProteasesIBA 11/2018
1	degrasynIBA 11/2018
1	FlavonoidsIBA 10/2018
1	PhytochemicalsIBA 10/2018
1	AntioxidantsIBA 10/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Free RadicalsIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	PQQ Cofactor (Pyrroloquinoline Quinone)IBA 01/2018
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2017
1	PhenolsIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2017
1	CateninsIBA 05/2013
1	Small Interfering RNA (siRNA)IBA 05/2013
1	ZincIBA 04/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013
1	LigandsIBA 04/2013
1	IonsIBA 04/2013
1	capsanthinIBA 08/2011
1	Carotenoids (Carotene)IBA 08/2011
1	PPAR gammaIBA 08/2011
1	astaxanthine (astaxanthin)IBA 08/2011
1	bixinIBA 08/2011
1	Peroxisome ProliferatorsIBA 08/2011

Therapy/Procedure

6	Therapeutics 02/2022 - 10/2019
1	Drug Therapy (Chemotherapy) 10/2019
1	Liver Transplantation 01/2017